Kenji Furuno

Dr. Kenji Furuno


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in The Lancet
Verified
Journal Article
Closed access
TKTohru Kobayashi
Tohru Kobayashi
TSTsutomu Saji
Tsutomu Saji
TOTetsuya Otani
Tetsuya Otani
KTKazuo Takeuchi
Kazuo Takeuchi
TNTetsuya Nakamura
Tetsuya Nakamura
AMAkihiro Morikawa
Akihiro Morikawa

1 October 2020 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
TKTohru Kobayashi
Tohru Kobayashi
MAMamoru Ayusawa
Mamoru Ayusawa
HSHiroyuki Suzuki
Hiroyuki Suzuki
JAJun Abe
Jun Abe
SIShuichi Ito
Shuichi Ito
KTKei Takahashi
Kei Takahashi

1 August 2016 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
SFShigeto Fuse
Shigeto Fuse
NSNaoko Sakamoto
Naoko Sakamoto
MMMasashi Mikami
Masashi Mikami
SOShunichi Ogawa
Shunichi Ogawa
KHKenji Hamaoka
Kenji Hamaoka
SDShozaburo Doi
Shozaburo Doi

1 July 2004 in Experimental Hematology
Verified
Journal Article
Closed access
YTYasushi Takahata
Yasushi Takahata
ANAkihiko Nomura
Akihiko Nomura
HTHidetoshi Takada
Hidetoshi Takada
SOShouichi Ohga
Shouichi Ohga
KFKenji Furuno
Kenji Furuno
THToshiro Hara
Toshiro Hara

1 May 2018 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
MMMasaru Miura
Masaru Miura
TKTohru Kobayashi
Tohru Kobayashi
TKTetsuji Kaneko
Tetsuji Kaneko
MAMamoru Ayusawa
Mamoru Ayusawa
RFRyuji Fukazawa
Ryuji Fukazawa
KYKenichiro Yamamura
Kenichiro Yamamura
Importance Few studies with sufficient statistical power have shown the association of thezscore of the coronary arterial internal diameter with coronary events (CE) in patients with Kawasaki disease (KD) with coronary artery aneurysms (CAA). Objective To clarify the association of thezscore with time-dependent CE occurrence in patients with KD with CAA. Design, Setting, and Participants This multicenter, collaborative retrospective cohort study of 44 participating institutions included 1006 patients with KD younger than 19 years who received a coronary angiography between 1992 and 2011. Main Outcomes and Measures The time-dependent occurrence of CE, including thrombosis, stenosis, obstruction, acute ischemic events, and coronary interventions, was analyzed for small (zscore, <5), medium (zscore, ≥5 to <10; actual internal diameter, <8 mm), and large (zscore, ≥10 or ≥8 mm) CAA by the Kaplan-Meier method. The Cox proportional hazard regression model was used to identify risk factors for CE after adjusting for age, sex, size, morphology, number of CAA, resistance to initial intravenous immunoglobulin (IVIG) therapy, and antithrombotic medications. Results Of 1006 patients, 714 (71%) were male, 341 (34%) received a diagnosis before age 1 year, 501 (50%) received a diagnosis between age 1 and 5 years, and 157 (16%) received a diagnosis at age 5 years or older. The 10-year event-free survival rate for CE was 100%, 94%, and 52% in men (P < .001) and 100%, 100%, and 75% in women (P < .001) for small, medium, and large CAA, respectively. The CE-free rate was 100%, 96%, and 79% in patients who were not resistant to IVIG therapy (P < .001) and 100%, 96%, and 51% in patients who were resistant to IVIG therapy (P < .001), respectively. Cox regression analysis revealed that large CAA (hazard ratio, 8.9; 95% CI, 5.1–15.4), male sex (hazard ratio, 2.8; 95% CI, 1.7–4.8), and resistance to IVIG therapy (hazard ratio, 2.2; 95% CI, 1.4–3.6) were significantly associated with CE. Conclusions and Relevance Classification using the internal diameterzscore is useful for assessing the severity of CAA in relation to the time-dependent occurrence of CE and associated factors in patients with KD. Careful management of CE is necessary for all patients with KD with CAA, especially men and IVIG-resistant patients with a large CAA.

1 May 2005 in Blood
Verified
Journal Article
Closed access
PDF file
EIEiichi Ishii
Eiichi Ishii
IUIkuyo Ueda
Ikuyo Ueda
RSRyutaro Shirakawa
Ryutaro Shirakawa
KYKen Yamamoto
Ken Yamamoto
HHHisanori Horiuchi
Hisanori Horiuchi
MYMasaki Yasukawa
Masaki Yasukawa
Mutations of the perforin (PRF1) and MUNC13-4 genes distinguish 2 forms of familial hemophagocytic lymphohistiocytosis (FHL2 and FHL3, respectively), but the clinical and biologic correlates of these genotypes remain in question. We studied the presenting features and cytotoxic T lymphocyte/natural killer (CTL/NK) cell functions of 35 patients for their relationship to distinct FHL subtypes. FHL2 (n = 11) had an earlier onset than either FHL3 (n = 8) or the non-FHL2/FHL3 subtype lacking a PRF1 or MUNC13-4 mutation (n = 16). Deficient NK cell activity persisted after chemotherapy in all cases of FHL2, whereas some patients with FHL3 or the non-FHL2/FHL3 subtype showed partial recovery of this activity during remission. Alloantigen-specific CTL-mediated cytotoxicity was deficient in FHL2 patients with PRF1 nonsense mutations, was very low in FHL3 patients, but was only moderately reduced in FHL2 patients with PRF1 missense mutations. These findings correlated well with Western blot analyses showing an absence of perforin in FHL2 cases with PRF1 nonsense mutations and of MUNC13-4 in FHL3 cases, whereas in FHL2 cases with PRF1 missense mutations, mature perforin was present in low amounts. These results suggest an association between the type of genetic mutation in FHL cases and the magnitude of CTL cytolytic activity and age at onset.